Causes of Orthostatic Hypotension
Orthostatic hypotension results from three primary mechanisms: autonomic nervous system dysfunction (neurogenic), volume depletion/blood loss, and medication effects—with aging, polypharmacy, and neurodegenerative diseases being the most common culprits in clinical practice.
Primary Etiologic Categories
Neurogenic Orthostatic Hypotension
This represents autonomic nervous system failure and divides into two distinct groups 1, 2:
Primary Autonomic Failure:
- Pure autonomic failure
- Multiple system atrophy
- Parkinson's disease
- Dementia with Lewy bodies
Secondary Autonomic Failure:
- Diabetes mellitus (most common)
- Amyloidosis
- Spinal cord injuries
- Autoimmune autonomic neuropathy
- Paraneoplastic autonomic neuropathy
- Kidney failure
Neurogenic OH is particularly important because it may be the earliest clinical manifestation of Parkinson's disease or related synucleinopathies, and it frequently coincides with supine hypertension 3.
Medication-Induced Orthostatic Hypotension
This is frequently overlooked, especially in the context of polypharmacy 4. The most common offending drug classes include:
- Diuretics (volume depletion)
- β-blockers (impaired compensatory tachycardia)
- Calcium channel blockers (vasodilation)
- ACE inhibitors/ARBs (vasodilation)
- Antidepressants (particularly tricyclics)
- Antiparkinsonian therapies (dopaminergic effects)
- Alpha-blockers (vasodilation)
- Nitrates (vasodilation)
Volume Depletion and Blood Loss
- Dehydration
- Acute or chronic blood loss
- Inadequate fluid intake (common in elderly)
Age-Related Physiological Changes
Aging itself causes baroreflex impairment, reduced cardiac compliance, and decreased responsiveness to compensatory mechanisms. This explains why OH affects 10-30% of elderly individuals 4, 5.
Clinical Context: Why This Matters
The distinction between neurogenic and non-neurogenic OH is critical because it fundamentally changes management and prognosis 3. Neurogenic OH typically requires more aggressive pharmacological intervention and carries implications for underlying neurodegenerative disease progression, while non-neurogenic OH often responds to addressing the precipitating cause (medication adjustment, volume repletion).
Common Pitfalls to Avoid:
- Missing medication-induced OH in polypharmacy patients—always conduct systematic medication review 4
- Failing to screen for supine hypertension in neurogenic OH patients, which complicates treatment 3, 5
- Not checking for postprandial hypotension, which frequently coexists and requires different timing of interventions 6
- Overlooking asymptomatic OH in high-risk groups (adults >70 with frailty, neurodegenerative disorders, unexplained falls) 6
Diagnostic Approach
When evaluating OH, look for these specific clinical clues:
For Neurogenic Causes:
- Symptoms without compensatory tachycardia
- Supine hypertension
- Other autonomic symptoms (anhidrosis, constipation, urinary retention)
- Known Parkinson's disease or diabetes
For Non-Neurogenic Causes:
- Recent medication changes
- Evidence of volume depletion (poor oral intake, diarrhea, bleeding)
- Preserved heart rate response to standing
- Absence of other autonomic symptoms
The prevalence increases dramatically with age and comorbidities—diabetes and Parkinson's disease coupled with aging result in 10-30% prevalence in the elderly 5.